 Twist Bioscience Corp NASDAQ: TWST and Eleven Therapeutics have created a replicon tool that could be used for studying viral genome replication, antiviral drug screening, and vaccine therapeutic development. Replicons are synthetic viral RNA molecules that mimic viruses in their ability to replicate but have been engineered to remove the portion of the genome that causes harm infectiousness. 